Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "continuous renal replacement therapy"

FDA approves Baxter's Phoxillum Renal Replacement Solution
Pharmaceutical Business Review

Baxter receives FDA approval for phoxillum solution for electr...

Baxter International reports that FDA has approved Phoxillum replacement solution for use in continuous renal replacement therapy. The product is used to correct electrolyte and acid-base imbalances during CRRT and, in case of drug poisoning, when ..., 1 hour ago
FDA approves renal therapy solution Formulary Journal, 3 days ago

Correction of Hyper- and Hyponatraemia during Continuous Renal Replacement Therapy

General Please address all your queries or problem reports to the Pay-per-View Customer Service at referring to PPV or PPV account. 1. All payments are by credit card only. The transaction is secure: standard-procedure SSL or ...
 Sexual Development2 weeks ago Trimethoprim and Sulfamethoxazole Transmembrane Clearance during Modeled Continuous Renal Replacement Therapy  Sexual Development1 month ago

FDA Approves Rockwell Medicall's Triferic For Iron Replacement And Maintenance Of Hemoglobin In Hemodialysis Patient

WIXOM, Mich., Jan. 26, 2015 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for ...
 BioSpace3 hours ago FDA Says Yes to Rockwell Medical (RMTI)'s Iron Replacement Drug 1/26/2015  ClinicSpace5 hours ago U.S. FDA Approves Rockwell's Triferic(TM) for Iron Replacement and Maintenance of Hemoglobin in Hemodialysis Patients  Vision Monday6 hours ago FDA Approves Natpara® (parathyroid hormone) for Injection as an Adjunct to Calcium and Vitamin D to Control Hypocalcemia in Patients with Hypoparathyroidism  Pettinga Financial Advisors2 days ago

Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac Endpoints From Fabry Monotherapy Study 011 and Long Term Extension Study

Statistically Significant Improvements in Key Cardiac Parameter Continued Improvement Out to 36 Months on Key Cardiac Parameter Further Strengthens Data Package for Upcoming Regulatory Submissions CRANBURY, N.J., Jan. 8, 2015 (GLOBE NEWSWIRE) -- ...
 Pettinga Financial Advisors2 weeks ago Amicus Therapeutics, Inc. Announces Positive Phase 3 Data On Cardiac Endpoints From Fabry Monotherapy Study 011 And Long Term Extension Study  BioSpace2 weeks ago

R KLaxmantaken off ventilator support

Comment · print · T T T+· T- TOPICS While legendary cartoonist R.K. Laxman continues to be in a critical condition, he has been taken off ventilator support, which brings hope of a recovery, said medical sources on Friday. Citing a ...
 The Hindu3 days ago Veteran cartoonist RK Laxman's health improves  DNA India3 days ago R.K.Laxmantaken off ventilator support  The Hindu3 days ago

MDGN: Positive MDGN-201 Data Through 7 Months

By Brian Marckx, CFA NYSE:MDGN TARGT EPO Trial Data Continues To Look Promising, Addl Data Expected To Be Forthcoming In mid-October Medgenics ( MDGN ) presented initial results from the MDGN-201 study which is using TARGT EPO with a new ...
 Yahoo! Finance1 week ago

Diaverum Enters Asian Market by Acquiring Kidney Centres in Kazakhstan

[January 16, 2015] Diaverum, one of the world's leading renal care providers, today announced the acquisition of Nefros Asia in Kazakhstan with nine kidney centres across the country. The centres will shortly begin the ...
 TMC Net1 week ago

CPXX: The DSMB Recommends Phase III to Continue

By Grant Zeng, CFA NASDAQ:CPXX On Dec. 1, 2014, Celator ( CPXX ) announced that the independent Data and Safety Monitoring Board (DSMB) for the Company's Phase III clinical study of CPX-351 has completed a second planned safety review and ...
 Yahoo! Finance1 month ago
Tutorial Finder

NXSTAGE MEDICAL : Establishes Annual Zenith Award To Recognize Excellence in Acute Renal Care

LAWRENCE, Mass., Jan. 20, 2015 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the creation of its annual Zenith Award to recognize acute renal care teams for their ...
 4 Traders6 days ago NxStage Establishes Annual Zenith Award To Recognize Excellence in Acute Renal Care  Tutorial Finder6 days ago

Data Investigating KEYTRUDA® (pembrolizumab), Merck's Anti-PD-1 Therapy, in Patients with Advanced Triple-Negative Breast Cancer Presented at 2014 San Antonio Breast Cancer Symposium

Merck ( NYSE: MRK ), known as MSD outside the United States and Canada, announced today early study findings demonstrating an overall response rate of 18.5 percent with KEYTRUDA, the company's anti-PD-1 therapy, as assessed by ...
 Street Sweeper1 month ago MERCK : Data Investigating KEYTRUDA® (pembrolizumab), Merck's Anti-PD-1 Therapy, in Patients with Advanced Triple-Negative Breast Cancer Presented at 2014 San Antonio Breast Cancer Symposium  4 Traders1 month ago Data Investigating KEYTRUDA(r) (pembrolizumab), Merck's Anti-PD-1 T...  Finwin1 month ago Eli Lilly, Merck & Co. Enter Collaboration Agreement To Research Immuno-Oncology Combination Regimens In Multiple Types Of Cancer  BioSpace1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less